CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 27 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $117,000 | -8.6% | 67,554 | +2.6% | 0.00% | – |
| Q3 2016 | $128,000 | +11.3% | 65,846 | -0.3% | 0.00% | – |
| Q2 2016 | $115,000 | +69.1% | 66,072 | +32.1% | 0.00% | – |
| Q1 2016 | $68,000 | -25.3% | 50,011 | -7.3% | 0.00% | – |
| Q4 2015 | $91,000 | -9.9% | 53,975 | +3.8% | 0.00% | – |
| Q3 2015 | $101,000 | -1.0% | 52,014 | +37.5% | 0.00% | – |
| Q2 2015 | $102,000 | – | 37,834 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,629,464 | $14,208,926 | 10.61% |
| Lynx1 Capital Management LP | 1,369,927 | $11,945,763 | 9.96% |
| Versant Venture Management, LLC | 543,753 | $4,741,526 | 9.88% |
| Foresite Capital Management IV, LLC | 1,787,094 | $15,583,460 | 8.09% |
| Octagon Capital Advisors LP | 4,570,918 | $39,858,405 | 5.74% |
| ACUTA CAPITAL PARTNERS, LLC | 878,500 | $7,660,520 | 5.64% |
| TCG Crossover Management, LLC | 3,048,257 | $26,580,801 | 5.18% |
| Affinity Asset Advisors, LLC | 1,083,118 | $9,444,789 | 3.12% |
| Altium Capital Management LP | 620,000 | $5,406,400 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 2,500,000 | $21,800 | 2.72% |